Regorafenib
bayer
[]
the data from the final analysis of the refine real world, prospective, observational study in patients with unresectable #hcc are in. #ascogi. #hccsm, #gi23 
Driving innovation in cancer care for patients around the world.
Community guidelines: https://t.co/SCn8hWF4Mt